{'52WeekChange': 0.13978493,
 'SandP52WeekChange': None,
 'address1': '4131 ParkLake Avenue',
 'address2': 'Suite 225',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 4.12,
 'askSize': 1800,
 'averageDailyVolume10Day': 740575,
 'averageVolume': 924879,
 'averageVolume10days': 740575,
 'beta': 0.75238,
 'beta3Year': None,
 'bid': 3.89,
 'bidSize': 2200,
 'bookValue': 0.767,
 'category': None,
 'circulatingSupply': None,
 'city': 'Raleigh',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 4.22,
 'dayLow': 4.04,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': 19.532,
 'enterpriseToRevenue': 3.044,
 'enterpriseValue': 395429472,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '919-582-9051',
 'fiftyDayAverage': 4.4542856,
 'fiftyTwoWeekHigh': 7.21,
 'fiftyTwoWeekLow': 2.85,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 86799381,
 'forwardEps': 0.48,
 'forwardPE': 8.479167,
 'fromCurrency': None,
 'fullTimeEmployees': 178,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.03076,
 'heldPercentInstitutions': 0.79727,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/bdsi.com',
 'longBusinessSummary': 'BioDelivery Sciences International, Inc., a specialty '
                        'pharmaceutical company, engages in the development '
                        'and commercialization of pharmaceutical products in '
                        'the United States and internationally. The company '
                        'provides its products based on its patented '
                        'BioErodible MucoAdhesive drug-delivery technology, a '
                        'small erodible polymer film for application to the '
                        'buccal mucosa, as well as other drug-delivery '
                        'technologies. It offers BELBUCA, a buprenorphine '
                        'buccal film for the treatment of chronic pain; '
                        'BUNAVAIL, a buprenorphine and naloxone buccal film to '
                        'treat opioid dependence; and ONSOLIS, a fentanyl '
                        'buccal soluble film for the management of '
                        'breakthrough pain in opioid tolerant adult patients '
                        'with cancer. The company also develops buprenorphine '
                        'extended release injection, an injectable '
                        'microparticle formulation of buprenorphine for the '
                        'treatment of opioid dependence and chronic pain. '
                        'BioDelivery Sciences International, Inc. was founded '
                        'in 1997 and is headquartered in Raleigh, North '
                        'Carolina.',
 'longName': 'BioDelivery Sciences International, Inc.',
 'market': 'us_market',
 'marketCap': 407671552,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_1541596',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -6506000,
 'nextFiscalYearEnd': 1640908800,
 'open': 4.22,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': 0.81,
 'phone': '919-582-9050',
 'previousClose': 4.24,
 'priceHint': 4,
 'priceToBook': 5.3063884,
 'priceToSalesTrailing12Months': 3.1383975,
 'profitMargins': -0.050079998,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 4.22,
 'regularMarketDayLow': 4.04,
 'regularMarketOpen': 4.22,
 'regularMarketPreviousClose': 4.24,
 'regularMarketPrice': 4.22,
 'regularMarketVolume': 1323555,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 99888800,
 'sharesPercentSharesOut': 0.0359,
 'sharesShort': 3593544,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 3312945,
 'shortName': 'BioDelivery Sciences Internatio',
 'shortPercentOfFloat': 0.0382,
 'shortRatio': 3.53,
 'startDate': None,
 'state': 'NC',
 'strikePrice': None,
 'symbol': 'BDSI',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -0.073,
 'twoHundredDayAverage': 4.629856,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '5de1ee11-3d6a-30d0-9c15-b754921fe2b9',
 'volume': 1323555,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.bdsi.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '27612'}